Literature DB >> 12352920

Detection of alloreactive T cells by flow cytometry: a new test compared with limiting dilution assay.

Aalzen De Haan1, Ieneke Van Der Gun, Wim Van Der Bij, Lou F M H De Leij, Jochum Prop.   

Abstract

BACKGROUND: Frequencies of alloreactive T cells determined by limiting dilution assays (LDA) may not adequately reflect the donor-reactive immune status in transplant recipients. To reevaluate LDA frequencies, we developed a flow cytometry test for direct determination of alloreactive T-cell frequencies and compared these frequencies with classical LDA estimates of frequencies.
METHODS: For determination of frequencies by flow cytometry, peripheral blood lymphocytes (or lymphocytes taken from primary mixed lymphocyte culture) were stimulated with either Epstein-Barr virus-transformed lymphoblastoid cell lines or T cell-depleted spleen cells and stained for intracellular interferon (IFN)-gamma production and CD69. In lung transplant recipients, frequencies of IFN+ alloreactive T cells were compared with LDA frequencies, that is, cytotoxic T lymphocyte precursors and helper T lymphocyte precursors.
RESULTS: With flow cytometry, alloreactive T cells were detected after overnight allostimulation as IFN-gamma CD69bright cells (range, 0.1-0.58% and 0.1-0.66% of total CD4 and CD8 cells, respectively). Frequencies increased 25-fold or more when lymphocytes were prestimulated in primary mixed lymphocyte culture before testing. After lung transplantation, mean donor-specific IFN+ CD8 T-cell frequencies did not decrease as mean donor-specific LDA cytotoxic T lymphocyte precursor frequencies, whereas no difference was seen in pretransplantation samples or third-party-specific frequencies at both time points. Mean frequencies of IFN+ CD4 did not differ from helper T lymphocyte precursors at both time points, but frequencies did not correlate.
CONCLUSIONS: The flow cytometry test allows a direct measurement of alloreactive T-cell frequencies and demonstrates a discrepancy between donor-specific IFN+ CD8 T-cell frequencies and LDA CLTp after transplantation. This may be a result of the existence of "functional diverse" alloreactive T cells or of activation-induced cell death of donor-reactive T cells during long (LDA) culturing, which is avoided in the flow cytometry test.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12352920     DOI: 10.1097/00007890-200208270-00023

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

1.  A novel high throughput immunomagnetic cell sorting system for potential clinical scale depletion of T cells for allogeneic stem cell transplantation.

Authors:  Xiaodong Tong; Ying Xiong; Maciej Zborowski; Sherif S Farag; Jeffrey J Chalmers
Journal:  Exp Hematol       Date:  2007-08-13       Impact factor: 3.084

Review 2.  Evolving Approaches in the Identification of Allograft-Reactive T and B Cells in Mice and Humans.

Authors:  James S Young; Christine McIntosh; Maria-Luisa Alegre; Anita S Chong
Journal:  Transplantation       Date:  2017-11       Impact factor: 4.939

3.  Proliferative alloresponse of T-cytotoxic cells identifies rejection-prone children with steroid-free liver transplantation.

Authors:  Chethan Ashokkumar; Qing Sun; Ankit Gupta; Brandon W Higgs; Tamara Fazzolare; Lisa Remaley; George Mazariegos; Kyle Soltys; Geoffrey Bond; Rakesh Sindhi
Journal:  Liver Transpl       Date:  2009-08       Impact factor: 5.799

4.  Allospecific CD154+ T cells associate with rejection risk after pediatric liver transplantation.

Authors:  C Ashokkumar; A Talukdar; Q Sun; B W Higgs; J Janosky; P Wilson; G Mazariegos; R Jaffe; A Demetris; J Dobberstein; K Soltys; G Bond; A W Thomson; A Zeevi; R Sindhi
Journal:  Am J Transplant       Date:  2008-10-31       Impact factor: 8.086

5.  Detailed kinetics of the direct allo-response in human liver transplant recipients: new insights from an optimized assay.

Authors:  Ozlem Tapirdamaz; Shanta Mancham; Luc J W van der Laan; Geert Kazemier; Kris Thielemans; Herold J Metselaar; Jaap Kwekkeboom
Journal:  PLoS One       Date:  2010-12-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.